Study for Safety and Effectiveness of RWJ-333369 (Carsibamate) for the Treatment of Diabetic Peripheral Neuropathy (DPN).

NCT00501202 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

132

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Neuropathy, Painful
Diabetic Neuralgia
Diabetic Polyneuropathy
Diabetic Mononeuropathy

Interventions

DRUG: placebo
DRUG: RWJ-333369 (carisbamate)

Sponsor

SK Life Science, Inc.